Radium RA 223

Ended Awarded Last action

Contract number
36C25519N0225
Awardee
Awarding agency
Obligated
$85,004

Award facts

Opportunity
Contract value 38% obligated
$225,003.56 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Wayne, NJ, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 -$54,996
Original award $140,000

About this award

This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a wholly-owned subsidiary of Bayer AG, for the supply of the pharmaceutical product RADIUM RA 223. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 and has a firm fixed price of $225,003.56. This award does not indicate the use of any set-aside program. Bayer Healthcare Pharmaceuticals Inc. is a major supplier of pharmaceuticals and medical products to federal government customers, including the Department of Veterans Affairs (VA) and the Defense Logistics Agency (DLA). The company has previously provided specialty pharmaceuticals, antibiotics, antimalarials, contraceptives, and contrast media through indefinite delivery contracts and blanket purchase agreements with these agencies to support the healthcare needs of veterans, active duty military, and their families.

Quick answers

Who was awarded contract 36C25519N0225?

36C25519N0225 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on April 2, 2019.

How much is contract 36C25519N0225 worth?

The government has obligated $85,004 on 36C25519N0225. Its current value, with exercised options, is $225,004.

Is contract 36C25519N0225 an order under another contract?

Yes. 36C25519N0225 is a delivery order under V797P2202D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25519N0225 competed?

The extent of competition for 36C25519N0225 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award